CA
CA · CA · CA-DIN-02526182
RYBREVANT
ATC L01FX18
Last synced from Health Canada Drug Product Database (Canada) on
Identification
ManufacturerJANSSEN INC
CountryCA (CA)
ATC codeL01FX18
Dispensing—
ReimbursedNo
SourceHealth Canada Drug Product Database (Canada)
Last synced6/11/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"din": "02526182",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "L01FX18",
"schedule": [
"Schedule D",
"Prescription"
],
"drug_code": "101529",
"strengths": [
"350 MG"
],
"ahfs_class": null,
"substances": [
"AMIVANTAMAB"
],
"product_categorization": null
}Related drugs
Other records sharing ATC code L01FX18.
- NORybrevantJanssen-Cilag International N.V.
- PLRybrevantJanssen-Cilag International N.V.
- ISRybrevantJanssen-Cilag International NV*
- ISRybrevantJanssen-Cilag International NV*
- ISRybrevantJanssen-Cilag International NV*
- ISRybrevantJanssen-Cilag International NV*
- ISRybrevantJanssen-Cilag International NV*
- PLRybrevantJanssen-Cilag International N.V.
Access this data programmatically
Query RYBREVANT and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.